KALA BIO scraps development of eye disease drug after trial failure-March 2024-www.financetom.com

KALA BIO scraps development of eye disease drug after trial failure

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

KALA BIO scraps development of eye disease drug after trial failure

Sep 29, 2025 5:41 AM

Sept 29 (Reuters) - KALA BIO ( KALA ) said on Monday it

will stop developing its experimental treatment for a type of

eye disease after it failed to meet the main goal in a mid-stage

study.

Previous page： Amentum Holdings Wins $105 Million Contract to Support Navy's Electronic Warfare Systems Next page： Omnicom Inks $13 Billion Deal For Interpublic: Will It Topple WPP As Top Ad Company?

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Amentum Holdings Wins $105 Million Contract to Support Navy's Electronic Warfare Systems

Dec 9, 2024

10:24 AM EST, 12/09/2024 (MT Newswires) -- Amentum Holdings ( AMTM ) said Monday it has been awarded a $105 million contract to support the US Navy's Airborne Electronic Attack Systems Division in advancing Electronic Warfare and Intelligence, Surveillance, and Reconnaissance systems. As part of the contract, the company will replace outdated components and integrate advanced technology to enhance EW...

Omnicom Inks $13 Billion Deal For Interpublic: Will It Topple WPP As Top Ad Company?

Dec 9, 2024

Omnicom Group Inc ( OMC ) agreed Monday to acquire Interpublic Group of Companies, Inc ( IPG ) in a stock-for-stock transaction. Interpublic shareholders will receive 0.344 Omnicom ( OMC ) shares for each share of Interpublic common stock. Should the transaction close, Omnicom ( OMC ) shareholders will own 60.6% of the combined company, and Interpublic shareholders will own...

Cadbury-owner Mondelez exploring Hershey acquisition, Bloomberg News reports

Dec 9, 2024

(Reuters) -Cadbury-parent Mondelez International ( MDLZ ) is exploring the acquisition of chocolate maker Hershey, Bloomberg News reported on Monday, citing people familiar with the matter, in what would create one of the world's largest confectioner. Shares of Hershey rose 17%, while those of Mondelez ( MDLZ ) were down about 4%. Mondelez ( MDLZ ) has made a preliminary...

Concentra Expands in Tennessee With New Knoxville Medical Center

Dec 9, 2024

10:21 AM EST, 12/09/2024 (MT Newswires) -- Concentra Group (CON) said Monday it is opening a new medical center in Knoxville, Tennessee that will offer various occupational medicine services, including telemedicine for minor work injuries. The Concentra Knoxville West medical center's services will include work injury care, physical therapy, drug testing, Department of Transportation physical exams, preplacement exams, and other...